TLR4 and inflammasome pathways are implicated in the pathogenesis of autoimmune diseases such as rheumatoid arthritis (26–28), and TNFα blockade specifically alters these responses by its effect on NFkB, playing a key role in NLRP3 priming (26, 29). Here, TNF is linked to rheumatoid arthritis.